Stearoylethanolamide (SEA) is an endocannabinoid neurotransmitter.[1]
Names | |
---|---|
IUPAC name
N-(2-Hydroxyethyl)octadecanamide
| |
Identifiers | |
| |
3D model (JSmol)
|
|
ChemSpider |
|
ECHA InfoCard | 100.003.531 |
| |
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C20H41NO2 | |
Molar mass | 327.553 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
|
Stearoylethanolamide (C20H41NO2; 18:0), also called N-(octadecanoyl)ethanolamine, is an N-acylethanolamine and the ethanolamide of octadecanoic acid (C18H36O2; 18:0) and ethanolamine (MEA: C2H7NO), and functionally related to an octadecanoic acid.[2]
Levels of SEA correlate with changes in pain intensity, indicating this SEA change, reflect the pain reduction effects of IPRP.[3]
{{cite journal}}
: CS1 maint: multiple names: authors list (link)